Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sprott Asset Management Betting Heavily on Aemetis Inc (AMTX)’s Turnaround

Eric Sprott‘s Sprott Asset Management has initiated a new position in Aemetis Inc (NASDAQ:AMTX) according to a recent 13G filling with the Securities and Exchange Commission. The holding is comprised of 1.23 million shares and represents 6.2% of the outstanding common stock of the producer of renewable fuels and biochemicals.



Toronto-based fund Sprott Asset Management dates back to 1981. Among the accolades of its founder, Eric Sprott, is his award for being the most influential hedge fund manager in 2012, bestowed by Terrapinn Inc. Sprott Management offers a wide variety of investment solutions and its product offerings include mutual funds, alternative strategies, physical bullion trusts and tax-efficient funds. Currently, the fund has about $2.94 billion worth of assets under management and the market value of its public equity portfolio stood at $1.26 billion at the end of the first quarter. The finance and energy sectors accounted for 37% and 15% of the holdings respectively, with its top equity picks being CGI Technologies and Solutions Inc (NYSE:GIB), Talisman Energy Inc. (USA) (NYSE:TLM), and NXP Semiconductors NV (NASDAQ:NXPI), which we’ll look at later in the article.


Eric Sprott
Sprott Asset Management

As far as the importance of tracking hedge funds is concerned, we discovered through our research that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month between 1999 and 2012. On the other hand the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. In forward tests since August 2012 through March 2015 the top 15 small-cap stocks beat the market by a hefty 84 percentage points, returning over 144% (read the details here). Hence a retail investor needs to isolate himself from the herd of investors chasing large-cap stocks and take advantage of the prevalent arbitrage opportunities in the market by concentrating on these money-making small-cap stocks.

Suffering from a decline in the price of ethanol and wet distiller’s grains, Aemetis Inc (NASDAQ:AMTX) reported $34.7 million in revenues for the first three months of the year, as compared to $60.7 million in the same quarter last year. This resulted in a net loss per share of $0.42 as compared to an EPS of $0.38 in the first quarter of 2014. So far this year, Aemetis Inc (NASDAQ:AMTX)’s stock has slumped by over 27%. Since the beginning of the year, Aemetis has been expanding its biodiesel sales to truck operators in southern and western India following the Indian government’s permission to directly sell biodiesel without the intermediate involvement of the three national oil marketing companies. Another investor in Aemetis Inc (NASDAQ:AMTX) is Glenn Russell Dubin‘s Highbridge Capital, owning 70,800 shares valued at $299,000.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.